Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA : a phase 3, double-blind, randomised, placebo-controlled multicentre trial

Lipton, RB; Croop, R; Stock, DA; Madonia, J; Forshaw, M; Lovegren, M; Mosher, L; Coric, V; Goadsby, PJ

Croop, R (通讯作者),Pfizer, New York, NY 10017 USA.

LANCET NEUROLOGY, 2023; 22 (3):